FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385581419> ?p ?o ?g. }

• W4385581419 abstract "Tranexamic acid (TXA) has previously been shown to be effective in reducing intraoperative blood loss (IBL) and transfusion requirements in spine surgery. A conventional TXA regimen is a simple preoperative or intraoperative administration. However, the hyperfibrinolysis caused by surgical trauma lasts at least 24 h, and a single dose of TXA cannot cover the whole process of hyperfibrinolysis. Moreover, its ability to control postoperative blood loss (PBL) may be insufficient. Therefore, this study aimed to explore the effects and safety of sequential perioperative intravenous TXA for reducing bleeding after posterior lumbar interbody fusion (PLIF).Patients requiring PLIF were randomly divided into two groups. All patients were intravenously injected with 1 g of TXA 15 min before skin resection. Every day after the surgery, 200 ml saline was intravenously injected for 1-3 days in Group A, while Group B received 1 g of TXA instead of saline. The total blood loss (TBL), IBL, PBL, HCT, Hb, blood transfusion volume, inflammation-related indicators, and complications were recorded.TBL, PBL, and hidden blood loss (HBL) in Group B were significantly lower than those in Group A (P < 0.05). The maximum decreases in HCT and Hb in Group B were also significantly lower than those in Group A (P < 0.05), and the drainage removal time (DRT) was sooner in Group B than in Group A (P = 0.003). On the 3rd and 5th days after surgery, the level of CRP in Group B was significantly lower than that in Group A (P < 0.05). Similarly, IL-6 levels were significantly lower in Group B for the first 5 days postoperatively (P < 0.001). Sex, operation time, level of decompression, length of incision, and change in HCT were significant predictors of both TBL and HBL. TBL was also significantly associated with BMI and preoperative fibrinogen, while postoperative TXA was a significant predictor of HBL only.Intravenous injection of 1 g of TXA 15 min before skin resection combined with continuous intravenous injection of 1 g of TXA 1 to 3 days after PLIF can reduce postoperative bleeding and shorten the time to drainage tube removal. In addition, it can also inhibit the postoperative inflammatory response.ChiCTR2200056210." @default.
• W4385581419 created "2023-08-05" @default.
• W4385581419 creator A5000325848 @default.
• W4385581419 creator A5009055008 @default.
• W4385581419 creator A5011888094 @default.
• W4385581419 creator A5015114505 @default.
• W4385581419 creator A5028179790 @default.
• W4385581419 creator A5032567093 @default.
• W4385581419 creator A5034471264 @default.
• W4385581419 creator A5043446520 @default.
• W4385581419 creator A5046454314 @default.
• W4385581419 creator A5085279871 @default.
• W4385581419 creator A5091305811 @default.
• W4385581419 date "2023-08-04" @default.
• W4385581419 modified "2023-10-18" @default.
• W4385581419 title "The effect of sequential perioperative intravenous tranexamic acid in reducing postoperative blood loss and hidden blood loss after posterior lumbar interbody fusion: a randomized controlled trial" @default.
• W4385581419 cites W1563786598 @default.
• W4385581419 cites W163835151 @default.
• W4385581419 cites W1897449427 @default.
• W4385581419 cites W1969118658 @default.
• W4385581419 cites W1978404863 @default.
• W4385581419 cites W1993891915 @default.
• W4385581419 cites W2003921872 @default.
• W4385581419 cites W2018899738 @default.
• W4385581419 cites W2040538032 @default.
• W4385581419 cites W2049043796 @default.
• W4385581419 cites W2070081970 @default.
• W4385581419 cites W2083534799 @default.
• W4385581419 cites W2083669022 @default.
• W4385581419 cites W2088688755 @default.
• W4385581419 cites W2100730818 @default.
• W4385581419 cites W2104670106 @default.
• W4385581419 cites W2132296965 @default.
• W4385581419 cites W2143779031 @default.
• W4385581419 cites W2161468469 @default.
• W4385581419 cites W2174657578 @default.
• W4385581419 cites W2313632998 @default.
• W4385581419 cites W2340817514 @default.
• W4385581419 cites W2345414727 @default.
• W4385581419 cites W2526218277 @default.
• W4385581419 cites W2555182648 @default.
• W4385581419 cites W2556293386 @default.
• W4385581419 cites W2579097084 @default.
• W4385581419 cites W2592330893 @default.
• W4385581419 cites W2605806871 @default.
• W4385581419 cites W2765290794 @default.
• W4385581419 cites W2769213467 @default.
• W4385581419 cites W2791309329 @default.
• W4385581419 cites W2793666044 @default.
• W4385581419 cites W2892700033 @default.
• W4385581419 cites W2898990418 @default.
• W4385581419 cites W2899288620 @default.
• W4385581419 cites W2905308560 @default.
• W4385581419 cites W2907554752 @default.
• W4385581419 cites W2938792021 @default.
• W4385581419 cites W2938851913 @default.
• W4385581419 cites W2946701161 @default.
• W4385581419 cites W3009164479 @default.
• W4385581419 cites W3204293096 @default.
• W4385581419 cites W4225733837 @default.
• W4385581419 cites W4360600106 @default.
• W4385581419 cites W50135966 @default.
• W4385581419 doi "https://doi.org/10.3389/fmed.2023.1192971" @default.
• W4385581419 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37601774" @default.
• W4385581419 hasPublicationYear "2023" @default.
• W4385581419 type Work @default.
• W4385581419 citedByCount "0" @default.
• W4385581419 crossrefType "journal-article" @default.
• W4385581419 hasAuthorship W4385581419A5000325848 @default.
• W4385581419 hasAuthorship W4385581419A5009055008 @default.
• W4385581419 hasAuthorship W4385581419A5011888094 @default.
• W4385581419 hasAuthorship W4385581419A5015114505 @default.
• W4385581419 hasAuthorship W4385581419A5028179790 @default.
• W4385581419 hasAuthorship W4385581419A5032567093 @default.
• W4385581419 hasAuthorship W4385581419A5034471264 @default.
• W4385581419 hasAuthorship W4385581419A5043446520 @default.
• W4385581419 hasAuthorship W4385581419A5046454314 @default.
• W4385581419 hasAuthorship W4385581419A5085279871 @default.
• W4385581419 hasAuthorship W4385581419A5091305811 @default.
• W4385581419 hasBestOaLocation W43855814191 @default.
• W4385581419 hasConcept C141071460 @default.
• W4385581419 hasConcept C168563851 @default.
• W4385581419 hasConcept C2777397205 @default.
• W4385581419 hasConcept C2777785397 @default.
• W4385581419 hasConcept C2779637338 @default.
• W4385581419 hasConcept C2779936836 @default.
• W4385581419 hasConcept C2780014101 @default.
• W4385581419 hasConcept C2781219028 @default.
• W4385581419 hasConcept C2781413609 @default.
• W4385581419 hasConcept C2991743468 @default.
• W4385581419 hasConcept C31174226 @default.
• W4385581419 hasConcept C42219234 @default.
• W4385581419 hasConcept C71924100 @default.
• W4385581419 hasConceptScore W4385581419C141071460 @default.
• W4385581419 hasConceptScore W4385581419C168563851 @default.
• W4385581419 hasConceptScore W4385581419C2777397205 @default.
• W4385581419 hasConceptScore W4385581419C2777785397 @default.
• W4385581419 hasConceptScore W4385581419C2779637338 @default.
• W4385581419 hasConceptScore W4385581419C2779936836 @default.
• W4385581419 hasConceptScore W4385581419C2780014101 @default.

• next